Premature Filings Add To EU Regulatory Resource Challenge

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.

Staff Shortages
EMA and national regulatory authorities face challenges in recruiting new staff • Source: Shutterstock

With the COVID-19 pandemic declared over, the biggest challenge facing the European Medicines Agency is the “sustainability of our medicines regulatory network” due to a lack of resources, including staff, according to the EMA’s chief medical officer, Steffan Thirstrup. Exacerbating the problem are premature marketing applications from drug companies that divert precious resources, he said.

The comments came at a fireside chat at the TOPRA (The Organization for Professionals in Regulatory Affairs) Symposium in Lisbon,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

EU Biosimilar Filings, Opinions And Approvals

 
• By Saba Afreen

<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

EU Pharma Reform: What You Need to Know Now

 
• By Anabel Costa-Ferreira and Ian Schofield

As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

New EU Approvals

<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description